Showing results (291-300 of 410) with videos related to
Sort By:
Pageof 41
Gut|May 20, 2016
Tumour CD274 (PD-L1) expression and T cells in colorectal cancerYohei Masugi, Reiko Nishihara, Juhong Yang, et al.Cancer Immunology, Immunotherapy : CII|January 18, 2024
Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatmentJoanna Baginska, Allison Nau, Ilana Gomez Diaz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2020
Long-term Follow-up of Standard-Dose Pembrolizumab Plus Reduced-Dose Ipilimumab in Patients with Advanced Melanoma: KEYNOTE-029 Part 1BMatteo S Carlino, Alexander M Menzies, Victoria Atkinson, et al.Cancer|June 23, 2020
Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitisShilpa Grover, Michael Dougan, Kevin Tyan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2025
Unraveling Relatlimab-Specific Biology Using Biomarker Analyses in Patients with Advanced Melanoma in RELATIVITY-047Evan J Lipson, Sonia Dolfi, Hao Tang, et al.Cancer Immunology Research|April 11, 2025
First-in-Human Clinical Trial of Vaccination with WDVAX, a Dendritic Cell Activating Scaffold Incorporating Autologous Tumor Cell Lysate, in Metastatic Melanoma PatientsF Stephen Hodi, Anita Giobbie-Hurder, Kwasi Adu-Berchie, et al.The New England Journal of Medicine|April 21, 2015
Nivolumab and ipilimumab versus ipilimumab in untreated melanomaMichael A Postow, Jason Chesney, Anna C Pavlick, et al.Cancer Immunology Research|November 8, 2015
Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent ModelDavid A Reardon, Prafulla C Gokhale, Sarah R Klein, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2025
Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204Raymond Y Huang, Gilbert Youssef, Thomas Nelson, et al.NEJM Evidence|February 6, 2024
Overall Survival and Response with Nivolumab and Relatlimab in Advanced MelanomaGeorgina V Long, F Stephen Hodi, Evan J Lipson, et al.Pageof 41